CAS: 945228-49-9 - Citatuzumab bogatox
Formula:Unspecified
- Synonyms:
- Protein VB6-845 (synthetic)
- Immunoglobulin G, anti-(tumor antigen 17-1A) (synthetic Fab fragment) fusion protein with bouganin (synthetic deimmunized)
- Citatuzumab bogatox
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Citatuzumab bogatox REF: TM-T76799CAS: 945228-49-9 | - - - | To inquire | Tue 29 Oct 24 |
 | Citatuzumab REF: 3D-CLA1182CAS: 945228-49-9 | - - - | To inquire | Wed 06 Nov 24 |
| Citatuzumab Bogatox REF: 3D-CLA1182ACAS: 945228-49-9 | - - - | To inquire | Wed 06 Nov 24 |
Citatuzumab bogatox
CAS:945228-49-9
Citatuzumab bogatox is a recombinant immunotoxin targeting EpCAM with the toxin bouganin, inducing apoptosis in …
Color and Shape:
Solid
Ref: TM-T76799
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 29 Oct 2024
Citatuzumab
CAS:945228-49-9
Antibody-drug conjugate (ADC) Cituximab bogatox is a therapeutic agent comprising a Fab fragment of a …
Ref: 3D-CLA1182
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 6 Nov 2024
Citatuzumab Bogatox
CAS:945228-49-9
Antibody-drug conjugate (ADC) Cituximab bogatox is a therapeutic agent comprising a Fab fragment of a …
Ref: 3D-CLA1182A
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 6 Nov 2024
